Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer
Yissum Announces the Discovery of a Novel Small Molecule With Potent Anti-Metastatic Activity
March 11th, 2008
Yissum Ltd., the Technology Transfer Company of the Hebrew University of Jerusalem, announced that scientists from the School of Pharmacy at the Hebrew University of Jerusalem discovered a novel orally available drug that prevents metastasis formation in various types of cancers. The novel drug is a small molecule named cis-ACCP, which is a prototype of a family of compounds that may be administered orally and was shown as highly effective in rodents without inducing any adverse side-effects. The development of the drug was a collaborative effort of the laboratories of Prof. Eli Breuer, Prof. Reuven Reich and Prof. Amnon Hoffman, all from the School of Pharmacy at the Hebrew University of...
Source: Cancer Weekly (2008-03-11)
|
